Oncology & Cancer

Transplant patients have high rate of cancer death

Researchers at the University of Adelaide are working to better understand how patients who receive life-saving organ transplants can be spared from dying of cancer many years later.

Medications

Pfizer to pay $35M to settle drug marketing case

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.

page 9 from 14